Sanofi (SNY) Long-Term Debt Repayments (2016 - 2026)
Sanofi's Long-Term Debt Repayments history spans 15 years, with the latest figure at -$2.2 billion for Q1 2026.
- On a quarterly basis, Long-Term Debt Repayments rose 14.85% to -$2.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$4.6 billion, a 32.92% increase, with the full-year FY2025 number at -$2.6 billion, up 33.99% from a year prior.
- Long-Term Debt Repayments hit -$2.2 billion in Q1 2026 for Sanofi, up from -$2.6 billion in the prior quarter.
- Over the last five years, Long-Term Debt Repayments for SNY hit a ceiling of $3.6 billion in Q4 2022 and a floor of -$4.2 billion in Q2 2023.
- Historically, Long-Term Debt Repayments has averaged -$1.1 billion across 5 years, with a median of -$1.3 billion in 2023.
- The widest YoY moves for Long-Term Debt Repayments: up 526.6% in 2025, down 223.15% in 2025.
- Tracing SNY's Long-Term Debt Repayments over 5 years: stood at $3.6 billion in 2022, then tumbled by 140.33% to -$1.5 billion in 2023, then grew by 28.3% to -$1.0 billion in 2024, then tumbled by 148.8% to -$2.6 billion in 2025, then grew by 14.9% to -$2.2 billion in 2026.
- Business Quant data shows Long-Term Debt Repayments for SNY at -$2.2 billion in Q1 2026, -$2.6 billion in Q4 2025, and -$498.0 million in Q3 2025.